Bank of America’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.5M | Buy |
157,865
+37,696
| +31% | +$7.46M | ﹤0.01% | 2001 |
|
|
2025
Q4 | $22.7M | Sell |
120,169
-2,240
| -2% | -$430K | ﹤0.01% | 2188 |
|
|
2025
Q3 | $21.7M | Buy |
122,409
+6,601
| +6% | +$981K | ﹤0.01% | 2547 |
|
|
2025
Q2 | $13.2M | Buy |
115,808
+15,321
| +15% | +$1.64M | ﹤0.01% | 2962 |
|
|
2025
Q1 | $10.6M | Sell |
100,487
-6,952
| -6% | -$786K | ﹤0.01% | 3076 |
|
|
2024
Q4 | $11.5M | Buy |
107,439
+2,533
| +2% | +$286K | ﹤0.01% | 2805 |
|
|
2024
Q3 | $10.5M | Buy |
104,906
+2,456
| +2% | +$247K | ﹤0.01% | 3027 |
|
|
2024
Q2 | $8.63M | Sell |
102,450
-47,288
| -32% | -$3.76M | ﹤0.01% | 3086 |
|
|
2024
Q1 | $10.9M | Buy |
149,738
+37,038
| +33% | +$2.73M | ﹤0.01% | 2905 |
|
|
2023
Q4 | $8.05M | Buy |
112,700
+5,539
| +5% | +$327K | ﹤0.01% | 3114 |
|
|
2023
Q3 | $6.42M | Buy |
107,161
+18,313
| +21% | +$1.21M | ﹤0.01% | 3167 |
|
|
2023
Q2 | $6.41M | Buy |
88,848
+6,721
| +8% | +$504K | ﹤0.01% | 3162 |
|
|
2023
Q1 | $6.04M | Buy |
82,127
+7,860
| +11% | +$559K | ﹤0.01% | 3355 |
|
|
2022
Q4 | $4.96M | Sell |
74,267
-82,599
| -53% | -$5.37M | ﹤0.01% | 3394 |
|
|
2022
Q3 | $8.43M | Buy |
156,866
+36,043
| +30% | +$2.12M | ﹤0.01% | 2792 |
|
|
2022
Q2 | $6.72M | Sell |
120,823
-78,215
| -39% | -$4.44M | ﹤0.01% | 3082 |
|
|
2022
Q1 | $14M | Buy |
199,038
+62,389
| +46% | +$4.53M | ﹤0.01% | 2526 |
|
|
2021
Q4 | $13.2M | Buy |
136,649
+11,974
| +10% | +$1.11M | ﹤0.01% | 2643 |
|
|
2021
Q3 | $10.8M | Sell |
124,675
-6,749
| -5% | -$522K | ﹤0.01% | 2762 |
|
|
2021
Q2 | $10.8M | Buy |
131,424
+8,197
| +7% | +$682K | ﹤0.01% | 2760 |
|
|
2021
Q1 | $11.7M | Sell |
123,227
-234,412
| -66% | -$22.2M | ﹤0.01% | 2568 |
|
|
2020
Q4 | $22.2M | Buy |
357,639
+2,732
| +0.8% | +$156K | ﹤0.01% | 1781 |
|
|
2020
Q3 | $21.1M | Buy |
354,907
+96,846
| +38% | +$6.61M | ﹤0.01% | 1659 |
|
|
2020
Q2 | $18M | Buy |
258,061
+53,602
| +26% | +$3.4M | ﹤0.01% | 1697 |
|
|
2020
Q1 | $9.28M | Sell |
204,459
-264,197
| -56% | -$15M | ﹤0.01% | 2120 |
|
|
2019
Q4 | $30.5M | Buy |
468,656
+9,489
| +2% | +$634K | ﹤0.01% | 1531 |
|
|
2019
Q3 | $28.5M | Buy |
459,167
+237,931
| +108% | +$14.9M | ﹤0.01% | 1535 |
|
|
2019
Q2 | $15.8M | Sell |
221,236
-24,711
| -10% | -$1.82M | ﹤0.01% | 2090 |
|
|
2019
Q1 | $19.3M | Buy |
245,947
+82,064
| +50% | +$6.22M | ﹤0.01% | 1857 |
|
|
2018
Q4 | $13.9M | Buy |
163,883
+34,463
| +27% | +$3.67M | ﹤0.01% | 1988 |
|
|
2018
Q3 | $22.2M | Sell |
129,420
-40,040
| -24% | -$6.04M | ﹤0.01% | 1738 |
|
|
2018
Q2 | $21.9M | Sell |
169,460
-341,099
| -67% | -$38.1M | ﹤0.01% | 1740 |
|
|
2018
Q1 | $52.6M | Sell |
510,559
-288,424
| -36% | -$28.5M | 0.01% | 1018 |
|
|
2017
Q4 | $68.3M | Sell |
798,983
-714,635
| -47% | -$61.9M | 0.01% | 917 |
|
|
2017
Q3 | $129M | Buy |
1,513,618
+678,872
| +81% | +$53.8M | 0.02% | 646 |
|
|
2017
Q2 | $63.2M | Sell |
834,746
-111,458
| -12% | -$7.8M | 0.01% | 901 |
|
|
2017
Q1 | $62.5M | Buy |
946,204
+42,401
| +5% | +$2.79M | 0.01% | 907 |
|
|
2016
Q4 | $57.3M | Buy |
903,803
+65,211
| +8% | +$4.12M | 0.01% | 927 |
|
|
2016
Q3 | $53.4M | Buy |
838,592
+352,755
| +73% | +$25.9M | 0.01% | 936 |
|
|
2016
Q2 | $36.1M | Sell |
485,837
-9,208
| -2% | -$683K | 0.01% | 1179 |
|
|
2016
Q1 | $33.1M | Buy |
495,045
+9,564
| +2% | +$581K | 0.01% | 1187 |
|
|
2015
Q4 | $32.8M | Sell |
485,481
-54,926
| -10% | -$3.39M | 0.01% | 1264 |
|
|
2015
Q3 | $28.9M | Sell |
540,407
-270,511
| -33% | -$16.4M | 0.01% | 1340 |
|
|
2015
Q2 | $51M | Sell |
810,918
-56,505
| -7% | -$3.08M | 0.02% | 835 |
|
|
2015
Q1 | $41.7M | Buy |
867,423
+58,328
| +7% | +$2.23M | 0.01% | 914 |
|
|
2014
Q4 | $26.9M | Buy |
809,095
+111,835
| +16% | +$3.64M | 0.01% | 1175 |
|
|
2014
Q3 | $20.4M | Buy |
697,260
+677,663
| +3,458% | +$22.5M | 0.01% | 1383 |
|
|
2014
Q2 | $761K | Buy |
19,597
+31
| +0.2% | +$1.26K | ﹤0.01% | 4225 |
|
|
2014
Q1 | $821K | Sell |
19,566
-13,150
| -40% | -$548K | ﹤0.01% | 4113 |
|
|
2013
Q4 | $1.07M | Buy |
32,716
+26,956
| +468% | +$878K | ﹤0.01% | 3992 |
|
|
2013
Q3 | $156K | Sell |
5,760
-7,428
| -56% | -$209K | ﹤0.01% | 5659 |
|
|
2013
Q2 | $307K | Buy |
+13,188
| New | +$237K | ﹤0.01% | 5215 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Bank of America's LGND Position: Q1 2026 in Review
Bank of America increased its Ligand Pharmaceuticals (LGND) stake by 31% in Q1 2026, buying an estimated $7.46M and bringing the position to 157,865 shares worth $31.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2001.
Bank of America first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q3 2017. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Bank of America held 157,865 shares of Ligand Pharmaceuticals worth $31.5M as of Q1 2026.
- Bank of America bought 37,696 Ligand Pharmaceuticals shares in Q1 2026, an estimated $7.46M.
- Ligand Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2001 holding.
- Bank of America first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Ligand Pharmaceuticals position peaked at $129M in Q3 2017.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.